Quest Diagnostics Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains
Quest Diagnostics Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
本文由MarketWatch使用Automated Insights的技術自動生成。
Shares of Quest Diagnostics Inc. (DGX) rose 1.94% to $144.78 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.82% to 4,646.71 and Dow Jones Industrial Average falling 0.66% to 36,079.94. Quest Diagnostics Inc. closed $15.78 short of its 52-week high ($160.56), which the company reached on September 9th.
Quest Diagnostics Inc.股價週三上漲1.94%，至144.78美元，盤中股市全面低迷，標準普爾500指數下跌0.82%，至4,646.71點，道瓊斯工業股票平均價格指數下跌0.66%，至36,079.94點。Quest Diagnostics Inc.收盤價比該公司9月9日創下的52周高點(160.56美元)低15.78美元。
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Laboratory Corp. of America Holdings (LH) rose 2.64% to $283.84, Qiagen N.V. (QGEN) rose 0.28% to $53.25, and Sonic Healthcare Ltd. ADR fell 1.20% to $28.86. Trading volume (963,032) remained 356,500 below its 50-day average volume of 1.3 M.
週三，與一些競爭對手相比，該股表現喜憂參半，美國實驗室控股公司(Laboratory Corp.of America Holdings)上漲2.64%，至283.84美元，啟根公司(Qiagen N.V.)上漲0.28%，至53.25美元，Sonic Healthcare Ltd.美國存託憑證(Sonic Healthcare Ltd.)下跌1.20%，至28.86美元。成交量(963,032口)仍較其50天平均成交量130萬口低356,500口。
Data source: Dow Jones Market Data, FactSet. Data compiled November 10, 2021.
數據來源：道瓊斯市場數據，FactSet。數據彙編於2021年11月10日。
-MarketWatch Automation
-MarketWatch自動化